These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18637078)

  • 1. Where are people being tested for anti-HCV in England? Results from sentinel laboratory surveillance.
    Brant LJ; Hurrelle M; Balogun MA; Klapper P; Ramsay ME;
    J Viral Hepat; 2008 Oct; 15(10):729-39. PubMed ID: 18637078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C testing in sexual health services in England, 2002-7: results from sentinel surveillance.
    Tweed E; Brant L; Hurrelle M; Klapper P; Ramsay M;
    Sex Transm Infect; 2010 Apr; 86(2):126-30. PubMed ID: 19858534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel laboratory surveillance of hepatitis C antibody testing in England: understanding the epidemiology of HCV infection.
    Brant LJ; Hurrelle M; Balogun MA; Klapper P; Ahmad F; Boxall E; Hale A; Hollyoak V; Ibrahim IB; Irving W; Meigh R; Mutton KJ; Patel BC; Paver WK; Pugh S; Taylor C; Turner AJ; Ramsay ME
    Epidemiol Infect; 2007 Apr; 135(3):417-26. PubMed ID: 16836798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure to diagnose recent hepatitis C virus infections in London injecting drug users.
    Aarons E; Grant P; Soldan K; Luton P; Tang J; Tedder R
    J Med Virol; 2004 Aug; 73(4):548-53. PubMed ID: 15221898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
    Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
    BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots.
    Hope VD; Hickman M; Ngui SL; Jones S; Telfer M; Bizzarri M; Ncube F; Parry JV
    J Viral Hepat; 2011 Apr; 18(4):262-70. PubMed ID: 20456636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of, and risk factors for, hepatitis C virus infection among recent initiates to injecting in London and Glasgow: cross sectional analysis.
    Judd A; Hutchinson S; Wadd S; Hickman M; Taylor A; Jones S; Parry JV; Cameron S; Rhodes T; Ahmed S; Bird S; Fox R; Renton A; Stimson GV; Goldberg D
    J Viral Hepat; 2005 Nov; 12(6):655-62. PubMed ID: 16255768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus among self declared non-injecting sexual partners of injecting drug users.
    Roy KM; Goldberg DJ; Hutchinson S; Cameron SO; Wilson K; MacDonald L
    J Med Virol; 2004 Sep; 74(1):62-6. PubMed ID: 15258969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of premarket rapid hepatitis C virus antibody assays in 4 national human immunodeficiency virus behavioral surveillance system sites.
    Smith BD; Teshale E; Jewett A; Weinbaum CM; Neaigus A; Hagan H; Jenness SM; Melville SK; Burt R; Thiede H; Al-Tayyib A; Pannala PR; Miles IW; Oster AM; Smith A; Finlayson T; Bowles KE; Dinenno EA
    Clin Infect Dis; 2011 Oct; 53(8):780-6. PubMed ID: 21921221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus infection, HIV co-infection, and associated risk among injecting drug users in Togliatti, Russia.
    Rhodes T; Platt L; Judd A; Mikhailova LA; Sarang A; Wallis N; Alpatova T; Hickman M; Parry JV
    Int J STD AIDS; 2005 Nov; 16(11):749-54. PubMed ID: 16303071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indications of immune protection from hepatitis C infection.
    Aitken CK; Bowden S; Hellard M; Crofts N
    J Urban Health; 2004 Mar; 81(1):58-60. PubMed ID: 15047784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience of hepatitis C testing among injecting drug users in Sydney, Australia.
    Day CA; White B; Thein HH; Doab A; Dore GJ; Bates A; Holden J; Maher L
    AIDS Care; 2008 Jan; 20(1):116-23. PubMed ID: 18278622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Planning for the healthcare burden of hepatitis C infection: Hepatitis C genotypes identified in England, 2002-2007.
    Brant LJ; Ramsay ME; Tweed E; Hale A; Hurrelle M; Klapper P; Ngui SL;
    J Clin Virol; 2010 Jun; 48(2):115-9. PubMed ID: 20399704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of hepatitis C in an ethnically diverse HIV-1-infected cohort in south London.
    Mohsen AH; Murad S; Easterbrook PJ
    HIV Med; 2005 May; 6(3):206-15. PubMed ID: 15876288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for hepatitis C virus infection in Inland Brazil: an analysis of pooled epidemiological sectional studies.
    Souto FJ; Fontes CJ; Pignati LT; Pagliarini ME; Menezes Vda M; Martinelli Ade L; Figueiredo JF; Donadi EA; Passos AD
    J Med Virol; 2012 May; 84(5):756-62. PubMed ID: 22431023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus infection in South Australian prisoners: seroprevalence, seroconversion, and risk factors.
    Miller ER; Bi P; Ryan P
    Int J Infect Dis; 2009 Mar; 13(2):201-8. PubMed ID: 18790659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of hepatitis C virus infection in children admitted to an urban hospital.
    Gerner P; Wirth S; Wintermeyer P; Walz A; Jenke A
    J Infect; 2006 Apr; 52(4):305-8. PubMed ID: 16473408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring HIV testing in diverse healthcare settings: results from a sentinel surveillance pilot study.
    Tweed E; Hale A; Hurrelle M; Smith R; Delpech V; Ruf M; Klapper P; Ramsay M; Brant L
    Sex Transm Infect; 2010 Oct; 86(5):360-4. PubMed ID: 20427560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceptability of hepatitis C virus testing methods among injecting drug users.
    White B; Day C; Thein HH; Doab A; Bates A; Holden J; van Beek I; Maher L
    Drug Alcohol Rev; 2008 Nov; 27(6):666-70. PubMed ID: 19378449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C infection among recent initiates to injecting in England 2000-2008: Is a national hepatitis C action plan making a difference?
    Hope V; Parry JV; Marongui A; Ncube F
    J Viral Hepat; 2012 Jan; 19(1):55-64. PubMed ID: 22187945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.